查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球轉型生長因子市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按等級、按應用、按最終用戶、按地區
市場調查報告書
商品編碼
1389785

全球轉型生長因子市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按等級、按應用、按最終用戶、按地區

Transforming Growth Factor Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 345 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2024年全球轉化生長因子（TGF）市場規模將達3.9億美元，到2031年底預計將達到近7.4億美元。

雖然 TGF 市場上的許多公司提供各種產品和服務，但人們越來越關注成為 GMP 級產品和試劑的供應商。 這種專門的方法可確保更高的產品品質和成熟的分銷網絡。 生命科學產業是全球研發支出水準最高的產業之一，且投資預計將持續成長。 此外，研發和技術投資從北美和歐洲轉向亞太地區，特別是印度等擁有熟練勞動力和政府激勵措施的國家，預計也將推動市場成長。

開發新穎、高成本的產品來滿足生命科學研究人員日益複雜的需求正在引起消費者的猶豫，尤其是預算有限的研究團隊。 此外，某些生長因子價格昂貴，限制了許多實驗室的可用性。 研發部門缺乏熟練的專業人員是另一個挑戰，主要是由於工資水平低、任務要求高和培訓不足。 缺乏經驗豐富的人員以及研究設施的限制可能會阻礙全球市場的成長。

2022年美國市場約佔北美市場的94.1%。 美國藥品製造資本投資的增加和老牌製造商數量的增加正在推動市場銷售。 個人化藥物的商業化和新生物製劑研發的增加預計將進一步推動該國市場的發展。

2022年德國在歐洲市場的市佔率約為28.2%。 全球人均醫療保健費用的上升對醫療保健支出產生了重大影響。 我們在德國擁有生長因子產品的生產設施，並提高了產品的可用性。 此外，領先公司正在進行併購以擴大其產品組合，從而促進市場成長。

中國在東亞市場佔據主導地位，2022 年市佔率約 46.8%。 中國經濟的成長，加上CRO（合約藥物開發組織）和CMO（合約製造組織）的快速成長，正在推動市場銷售。 經濟、社會和環境的變化正在促進這些發展，減少國家成長結構的不平衡。

本報告調查了全球轉化生長因子市場，並提供了市場概述，以及按產品、等級、應用、最終用戶、區域以及進入市場的公司的競爭趨勢劃分的趨勢。我們提供

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第 3 章 2018-2031 年全球轉化生長因子市場展望

  • 2018-2031 年全球轉化生長因子市場前景（按產品）、價值（百萬美元）、數量（百萬單位）
  • 2018-2031 年全球轉化生長因子市場前景（按等級、價值（百萬美元）、數量（百萬單位））
  • 2018-2031 年全球轉化生長因子市場展望，按應用、價值（百萬美元）、數量（百萬單位）
  • 2018-2031 年全球轉換生長因子市場前景（按最終用戶劃分）、價值（百萬美元）、銷售量（百萬單位）
  • 2018-2031 年全球轉換生長因子市場前景（按地區、價值（百萬美元）、數量（百萬單位））

第 4 章北美轉化生長因子市場展望，2018-2031 年

第 5 章歐洲轉化生長因子市場展望，2018-2031

第 6 章亞太地區轉化生長因子市場展望，2018-2031 年

第 7 章拉丁美洲轉型生長因子市場展望，2018-2031 年

第 8 章中東與非洲轉型成長因素市場展望，2018-2031 年

第九章競爭態勢

  • 依用途和等級劃分的熱圖
  • 按製造商和等級劃分的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Thermo Fisher Scientific
    • Lonza Group AG
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd
    • Abcam plc.
    • Bio-Techne.
    • Sartorius CellGenix GmbH
    • Proteintech Group, Inc.
    • PeproTech Inc.
    • Cell Signaling Technology, Inc.
    • Meridian Bioscience Inc.
    • Applied Biological Materials (abm), Inc.
    • Akron Biotech
    • Leadgene Biomedical, Inc
    • GE Healthcare

第 10 章附錄

簡介目錄

Fairfield Market Research, a premier market research firm, has unveiled its latest report on the Transforming Growth Factor (TGF) market, projecting a robust growth trajectory. The global revenue for TGF market was recorded at US$ 390 million in 2024, and it is poised to reach valuation of nearly US$ 740 million by the end of 2031.

Fueling Global TGF Market Growth

Specialty Products and Asia Pacific Market Expansion: While many businesses in the TGF market offer a range of products and services, there is a growing focus on being a supplier of GMP-grade products and reagents. This specialized approach ensures higher product quality and a well-established distribution network. The life sciences industry, which boasts one of the highest R&D spending levels globally, is expected to continue increasing its investment. Furthermore, the shift in R&D and technology investments from North America and Europe to Asia Pacific, particularly in countries like India, with its skilled labor force and government incentives, is expected to drive market growth.

Potential Challenges

Lack of Skilled Professionals and High Product Costs: The development of novel, high-cost products to meet the increasingly complex requirements of life sciences researchers has created hesitation among consumers, particularly research teams with budget constraints. Additionally, certain growth factors come with a hefty price tag, limiting access for many laboratories. A shortage of skilled professionals in the research and development sector, primarily due to low pay scales, demanding duties, and insufficient training, poses another challenge. This shortage of experienced individuals, along with limitations in research facilities, may hamper global market growth.

Country-wise Insights

Booming U.S. Market: The U.S. market accounted for approximately 94.1% of the North America market in 2022. Increasing capital expenditure on pharmaceutical manufacturing and a growing number of established manufacturers within the U.S. have driven market sales. The commercialization of personalized pharmaceutical products and intensified research and development efforts in novel biologics are expected to further boost the market in the country.

Lucrative German Market: Germany held about 28.2% market share in the Europe market in 2022. The rising cost of healthcare per capita globally has significantly affected healthcare spending. The presence of production facilities for growth factor products in Germany has improved product availability. Moreover, major companies are engaging in mergers and acquisitions to expand their product portfolios, contributing to market growth.

Emerging Chinese Market: China dominated the East Asia market with a market share of approximately 46.8% in 2022. China's growing economy, coupled with a surge in Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) activities, has propelled market sales. Economic, social, and environmental shifts have contributed to these developments, reducing imbalances in the country's growth structure.

Competitive Landscape

Market players are employing strategies such as acquisitions, mergers, expansions, and product launches to enhance their market presence. Asia Pacific is witnessing significant Research and Development (R&D) investments by corporations aiming to diversify their product offerings and capture market share in emerging economies.

Key Market Players

  • Thermo Fisher Scientific
  • Lonza Group AG
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Abcam plc.
  • Bio-Techne.
  • Sartorius CellGenix GmbH
  • Proteintech Group, Inc.
  • PeproTech Inc.
  • Cell Signaling Technology, Inc.
  • Meridian Bioscience Inc.
  • Applied Biological Materials (abm), Inc.
  • Akron Biotech
  • Leadgene Biomedical, Inc
  • GE Healthcare

Key Segments Covered in Transforming Growth Factor Industry Research

Product:

  • Activin
  • Bone Morphogenetic Proteins (BMPs)
  • TGF-beta Proteins

Grade:

  • GMP Grade
  • Non-GMP Grade

Application:

  • Oncology Research
  • Hematology Research
  • Wound Healing Research
  • Dermatology Research
  • Cardiovascular Disease & Diabetes
  • Cell Therapy and Ex vivo Manufacturing
  • Others

End User:

  • Pharmaceutical and Biotechnology Companies
  • Research Centers & Academic Institutes
  • CMO and CDMO

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Transforming Growth Factor Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Transforming Growth Factor Market Outlook, 2018 - 2031

  • 3.1. Global Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Activin
      • 3.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 3.1.1.3. TGF-beta Proteins
  • 3.2. Global Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. GMP Grade
      • 3.2.1.2. Non-GMP Grade
  • 3.3. Global Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oncology Research
      • 3.3.1.2. Hematology Research
      • 3.3.1.3. Wound Healing Research
      • 3.3.1.4. Dermatology Research
      • 3.3.1.5. Cardiovascular Disease & Diabetes
      • 3.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 3.3.1.7. Others
  • 3.4. Global Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Pharmaceutical and Biotechnology Companies
      • 3.4.1.2. Research Centers & Academic Institutes
      • 3.4.1.3. CMO and CDMO
  • 3.5. Global Transforming Growth Factor Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Transforming Growth Factor Market Outlook, 2018 - 2031

  • 4.1. North America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Activin
      • 4.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 4.1.1.3. TGF-beta Proteins
  • 4.2. North America Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. GMP Grade
      • 4.2.1.2. Non-GMP Grade
  • 4.3. North America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oncology Research
      • 4.3.1.2. Hematology Research
      • 4.3.1.3. Wound Healing Research
      • 4.3.1.4. Dermatology Research
      • 4.3.1.5. Cardiovascular Disease & Diabetes
      • 4.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 4.3.1.7. Others
  • 4.4. North America Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Pharmaceutical and Biotechnology Companies
      • 4.4.1.2. Research Centers & Academic Institutes
      • 4.4.1.3. CMO and CDMO
  • 4.5. North America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.2. U.S. Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.3. U.S. Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031 by End User
      • 4.5.1.4. U.S. Transforming Growth Factor Market, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.5. Canada Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.6. Canada Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.7. Canada Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.8. Canada Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Transforming Growth Factor Market Outlook, 2018 - 2031

  • 5.1. Europe Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Activin
      • 5.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 5.1.1.3. TGF-beta Proteins
  • 5.2. Europe Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. GMP Grade
      • 5.2.1.2. Non-GMP Grade
  • 5.3. Europe Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oncology Research
      • 5.3.1.2. Hematology Research
      • 5.3.1.3. Wound Healing Research
      • 5.3.1.4. Dermatology Research
      • 5.3.1.5. Cardiovascular Disease & Diabetes
      • 5.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 5.3.1.7. Others
  • 5.4. Europe Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pharmaceutical and Biotechnology Companies
      • 5.4.1.2. Research Centers & Academic Institutes
      • 5.4.1.3. CMO and CDMO
  • 5.5. Europe Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.2. Germany Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.3. Germany Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.4. Germany Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.5. U.K. Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.6. U.K. Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.7. U.K. Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.8. U.K. Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.9. France Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.10. France Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.11. France Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.12. France Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.13. Italy Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.14. Italy Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.15. Italy Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.16. Italy Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.17. Turkey Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.18. Turkey Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.19. Turkey Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.20. Turkey Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.21. Russia Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.22. Russia Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.23. Russia Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.24. Russia Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.25. Rest of Europe Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.26. Rest of Europe Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.27. Rest of Europe Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.28. Rest of Europe Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Transforming Growth Factor Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Activin
      • 6.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 6.1.1.3. TGF-beta Proteins
  • 6.2. Asia Pacific Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. GMP Grade
      • 6.2.1.2. Non-GMP Grade
  • 6.3. Asia Pacific Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oncology Research
      • 6.3.1.2. Hematology Research
      • 6.3.1.3. Wound Healing Research
      • 6.3.1.4. Dermatology Research
      • 6.3.1.5. Cardiovascular Disease & Diabetes
      • 6.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 6.3.1.7. Others
  • 6.4. Asia Pacific Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pharmaceutical and Biotechnology Companies
      • 6.4.1.2. Research Centers & Academic Institutes
      • 6.4.1.3. CMO and CDMO
  • 6.5. Asia Pacific Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.2. China Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.3. China Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.4. China Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.5. Japan Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.6. Japan Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.7. Japan Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.8. Japan Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.9. South Korea Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.10. South Korea Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.11. South Korea Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.12. South Korea Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.13. India Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.14. India Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.15. India Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.16. India Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.17. Southeast Asia Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.18. Southeast Asia Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.19. Southeast Asia Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.20. Southeast Asia Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Transforming Growth Factor Market Outlook, 2018 - 2031

  • 7.1. Latin America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Activin
      • 7.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 7.1.1.3. TGF-beta Proteins
  • 7.2. Latin America Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.1. GMP Grade
      • 7.2.1.2. Non-GMP Grade
  • 7.3. Latin America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oncology Research
      • 7.3.1.2. Hematology Research
      • 7.3.1.3. Wound Healing Research
      • 7.3.1.4. Dermatology Research
      • 7.3.1.5. Cardiovascular Disease & Diabetes
      • 7.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 7.3.1.7. Others
  • 7.4. Latin America Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pharmaceutical and Biotechnology Companies
      • 7.4.1.2. Research Centers & Academic Institutes
      • 7.4.1.3. CMO and CDMO
  • 7.5. Latin America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.2. Brazil Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.3. Brazil Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.4. Brazil Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.5. Mexico Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.6. Mexico Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.7. Mexico Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.8. Mexico Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.9. Argentina Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.10. Argentina Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.11. Argentina Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.12. Argentina Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Transforming Growth Factor Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Activin
      • 8.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 8.1.1.3. TGF-beta Proteins
  • 8.2. Middle East & Africa Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. GMP Grade
      • 8.2.1.2. Non-GMP Grade
  • 8.3. Middle East & Africa Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oncology Research
      • 8.3.1.2. Hematology Research
      • 8.3.1.3. Wound Healing Research
      • 8.3.1.4. Dermatology Research
      • 8.3.1.5. Cardiovascular Disease & Diabetes
      • 8.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 8.3.1.7. Others
  • 8.4. Middle East & Africa Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pharmaceutical and Biotechnology Companies
      • 8.4.1.2. Research Centers & Academic Institutes
      • 8.4.1.3. CMO and CDMO
  • 8.5. Middle East & Africa Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.2. GCC Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.3. GCC Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.4. GCC Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.5. South Africa Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.6. South Africa Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.7. South Africa Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.8. South Africa Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.9. Egypt Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.10. Egypt Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.11. Egypt Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.12. Egypt Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.13. Nigeria Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.14. Nigeria Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.15. Nigeria Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.16. Nigeria Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. by Application vs by Grade Heatmap
  • 9.2. Manufacturer vs by Grade Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Thermo Fisher Scientific
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Lonza Group AG
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Merck KGaA
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. F. Hoffmann-La Roche Ltd
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Abcam plc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Bio-Techne.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Sartorius CellGenix GmbH
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Proteintech Group, Inc.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. PeproTech Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Cell Signaling Technology, Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Meridian Bioscience Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Applied Biological Materials (abm), Inc.
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Akron Biotech
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Leadgene Biomedical, Inc
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. GE Healthcare
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations